ViroGates A/S (CO:VIRO) — Stock Price
ViroGates A/S (CO:VIRO) is currently trading at Dkr10.10 DKK, down 7.34% today. Over the past 52 weeks, shares have ranged between Dkr9.05 and Dkr17.40. This page tracks ViroGates A/S's live share price on the CO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ViroGates A/S market capitalisation.
ViroGates A/S (VIRO) Stock Price Chart — Daily History & Trading Volume
The chart below tracks ViroGates A/S's daily closing share price and trading volume on the CO exchange over the past year, giving a clear view of recent price momentum and liquidity.
ViroGates A/S Income Statement — Revenue, Profit & Earnings by Year
ViroGates A/S's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | Dkr4.90 Million | Dkr6.99 Million | Dkr15.20 Million | Dkr7.66 Million | Dkr5.35 Million |
| Cost of Revenue | Dkr2.33 Million | Dkr1.18 Million | Dkr2.54 Million | Dkr1.87 Million | Dkr1.16 Million |
| Gross Profit | Dkr2.56 Million | Dkr5.80 Million | Dkr12.66 Million | Dkr5.79 Million | Dkr4.19 Million |
| Research & Development | Dkr6.91 Million | Dkr6.44 Million | Dkr10.58 Million | Dkr5.94 Million | Dkr5.80 Million |
| SG&A | Dkr3.78 Million | Dkr3.39 Million | Dkr3.95 Million | Dkr4.09 Million | Dkr3.97 Million |
| Total Operating Expenses | Dkr19.37 Million | Dkr18.37 Million | Dkr23.50 Million | Dkr24.58 Million | Dkr23.92 Million |
| Operating Income | Dkr-16.80 Million | Dkr-12.56 Million | Dkr-10.85 Million | Dkr-18.79 Million | Dkr-19.73 Million |
| EBITDA | Dkr-14.52 Million | Dkr-12.48 Million | Dkr-10.59 Million | Dkr-18.57 Million | Dkr-19.50 Million |
| EBIT | Dkr-14.56 Million | Dkr-12.52 Million | Dkr-10.76 Million | Dkr-18.79 Million | Dkr-19.73 Million |
| Interest Expense | Dkr658.00K | Dkr569.00K | Dkr112.00K | Dkr194.00K | Dkr287.00K |
| Income Before Tax | Dkr-15.18 Million | Dkr-13.09 Million | Dkr-10.88 Million | Dkr-18.96 Million | Dkr-19.98 Million |
| Income Tax Expense | Dkr-835.00K | Dkr-994.00K | Dkr-1.23 Million | Dkr-1.30 Million | Dkr-1.25 Million |
| Net Income | Dkr-14.35 Million | Dkr-12.10 Million | Dkr-9.65 Million | Dkr-17.66 Million | Dkr-18.74 Million |
ViroGates A/S Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes ViroGates A/S's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | Dkr17.66 Million | Dkr24.55 Million | Dkr17.54 Million | Dkr20.23 Million | Dkr38.25 Million |
| Total Current Assets | Dkr17.48 Million | Dkr24.38 Million | Dkr17.31 Million | Dkr19.84 Million | Dkr37.64 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Dkr1.62 Million | Dkr2.22 Million | Dkr2.43 Million | Dkr1.98 Million | Dkr1.96 Million |
| Inventory | Dkr2.81 Million | Dkr5.14 Million | Dkr3.77 Million | Dkr1.70 Million | Dkr907.00K |
| Property, Plant & Equipment | — | — | Dkr40.00K | Dkr216.00K | Dkr432.00K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Dkr6.87 Million | Dkr7.55 Million | Dkr1.45 Million | Dkr3.80 Million | Dkr6.93 Million |
| Total Current Liabilities | Dkr2.59 Million | Dkr2.25 Million | Dkr1.45 Million | Dkr3.80 Million | Dkr6.93 Million |
| Long-term Debt | Dkr4.27 Million | Dkr5.30 Million | Dkr0.00 | — | — |
| Net Debt | Dkr-6.91 Million | Dkr-10.73 Million | Dkr-9.88 Million | Dkr-14.86 Million | Dkr-33.53 Million |
| Total Stockholder Equity | Dkr10.79 Million | Dkr17.01 Million | Dkr16.09 Million | Dkr16.43 Million | Dkr31.31 Million |
| Retained Earnings | Dkr3.06 Million | Dkr10.56 Million | Dkr12.74 Million | Dkr13.26 Million | Dkr28.19 Million |
ViroGates A/S Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how ViroGates A/S generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | Dkr-11.95 Million | Dkr-12.18 Million | Dkr-14.28 Million | Dkr-21.44 Million | Dkr-15.60 Million |
| Capital Expenditures | Dkr0.00 | Dkr0.00 | Dkr0.00 | Dkr0.00 | Dkr114.00K |
| Free Cash Flow | Dkr-11.95 Million | Dkr-12.18 Million | Dkr-14.28 Million | Dkr-21.44 Million | Dkr-15.72 Million |
| Investing Cash Flow | Dkr-4.00K | Dkr12.00K | Dkr-13.00K | Dkr-4.00K | Dkr-114.00K |
| Financing Cash Flow | Dkr8.13 Million | Dkr18.32 Million | Dkr9.31 Million | Dkr2.78 Million | Dkr7.83 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Dkr0.00 | Dkr40.00K | Dkr175.00K | Dkr217.00K | Dkr229.00K |
| Change in Cash | Dkr-3.82 Million | Dkr6.15 Million | Dkr-4.98 Million | Dkr-18.67 Million | Dkr-7.88 Million |
ViroGates A/S Earnings History — EPS Actual vs. Analyst Estimates
Track ViroGates A/S's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 04, 2023 | -0.88 | — | — |
| Mar 29, 2023 | -0.53 | — | — |
| Nov 10, 2022 | -0.89 | — | — |
| Aug 18, 2022 | -0.61 | — | — |
| May 04, 2022 | -0.94 | — | — |
| Mar 23, 2022 | -1.27 | — | — |
| Nov 11, 2021 | -1.38 | — | — |
| Aug 19, 2021 | -1.62 | — | — |